Nezone Medicines Private Limited - Due diligence report

A 360° intelligence report on Nezone Medicines Private Limited: trust score, financial health, credit view, compliance, directors, growth an…

2002-04-22 Guwahati, Assam Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Nezone Medicines Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
78/100
Trust Score
Low Risk

Nezone Medicines Private Limited is assessed as Low Risk with a Trust Score of 78/100. Nezone Medicines Private Limited is an active private limited indian non-government company incorporated in 2002, operating in the Chemicals sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 30 Oct 2026 from the latest processed filings. Nezone Medicines Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
74/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.

Charges position: 0 open (-) · 3 satisfied (1.55 cr).

Banking relationships (from registered charges)
LenderChargesAmount
United Bank Of India1 48.0 cr
Canara Bank2 48.0 cr
Compliance Score: 74/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Litigation present in 2 court forum(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
HEMO PRAVA SAIKIA 01234567 Director 01/04/2018 6 yrs Approved
BANDANA SAIKIA 01234567 Director 01/04/2018 6 yrs Approved
DEBABRATA SAIKIA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
6 allotment(s) · 0 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Key managerial personnel: HEMO PRAVA SAIKIA (Whole-time director) · BANDANA SAIKIA (Whole-time director) · DEBABRATA SAIKIA (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 90
Growth signals & trust indicators
Operating for 24+ years.
Distress signals & risk flags
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence80/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment77/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view40/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
14 Jun 2017
Charge satisfied
United Bank Of India
17 Jan 2014
Director ceased
HEMO PRAVA SAIKIA
Director ceased
BANDANA SAIKIA
Director ceased
DEBABRATA SAIKIA
01 Mar 2013
Director appointed
HEMO PRAVA SAIKIA (Whole-time director)
Director ceased
KESHAV PATWARI
28 Feb 2013
Securities allotted
500.00 Equity Shares - 5,000.00 raised
28 Feb 2012
Securities allotted
100000.00 Equity Shares - 10.00 Lakh raised
18 Mar 2009
Securities allotted
68000.00 Equity Shares - 6.80 Lakh raised
Securities allotted
35000.00 Equity Shares - 3.50 Lakh raised
Securities allotted
150000.00 Equity Shares - 15.00 Lakh raised
25 Jan 2007
Securities allotted
1000.00 Equity Shares - 97.78 Lakh raised
28 Feb 2006
Charge created
United Bank Of India - 1.25 cr
10

Key Observations

Auto-generated from the data above
3 active director(s) / partner(s); board looks stable and experienced.
All 3 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a majority stake as per the FY 2017 annual return.
Capital has been raised through 6 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sipra Industries Private Limited U24231JH1987PTC002517 Ranchi, Jharkhand, India
Posian Pharma Private Limited U24232OR2010PTC011689 Khurda, Orissa, India
Navrang Paints Private Limited U24222RJ1995PTC010040 Udaipur, Rajasthan, India
Decent Polyplast Private Limited U25200DL2008PTC178026 Delhi, Delhi, India
Om Sri Godavari Agrochem Private Limited U24219TG2008PTC058788 Hyderabad, Telangana, India
Tejas Herbs India Private Limited U51900KA2010PTC055504 Bangalore, Karnataka, India
Sv Biofuel Private Limited U37100MP2013PTC030490 Indore, Madhya Pradesh, India
Super Star Fire-Tech Pvt Ltd U74999GJ1994PTC023412 Baroda, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Nezone Medicines Private Limited before audits and certifications: compliance score 74/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Nezone Medicines Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Nezone Medicines Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Nezone Medicines Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Nezone Medicines Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Nezone Medicines Private Limited an active company?

Nezone Medicines Private Limited has MCA status “Active” with a compliance score of 74/100 (Moderate).

Is Nezone Medicines Private Limited financially healthy?

Nezone Medicines Private Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Nezone Medicines Private Limited?

Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Nezone Medicines Private Limited?

Promoters hold a majority stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Nezone Medicines Private Limited have loans or charges against its assets?

No open charges - all 3 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Nezone Medicines Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 74/100 (Moderate).

Is it risky to lend to Nezone Medicines Private Limited?

Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.